Portfolio Update

RNS Number : 4930I
Intl. Biotechnology Trust PLC
21 March 2018
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

 

 

Portfolio Update as at 28 February 2018

 

Net Assets

£227m

Net Assets per share

605p

Share price

586p

Total value of unquoted investments

£22m

Total number of portfolio companies

95

Dividend

4% of NAV per annum

 

Top Ten Quoted Investments

 

Company Name

% NAV

Array

4.7

Biogen

4.2

Celgene

4.2

Neurocrine

4.2

Regeneron

3.7

Genmab

3.7

Sage

3.6

Vertex

3.6

Gilead

3.3

Exelixis

3.2


-----------

Total

38.4

 

Geographical Allocation

% NAV

US & Canada

89

Europe & UK

11


-----------

Total

100

 

 

Quoted/Unquoted Allocation

% NAV

Quoted

91

Unquoted

9


-----------

Total

100

 

 

NAV % Market Cap

% NAV

Large Cap >USD10BN

36

Mid Cap =USD1-10BN

37

Small Cap <USD1BN

27


-----------

Total

100

 

 

NAV % by Therapeutic Areas

% NAV

Oncology

38

Rare diseases

15

CNS

14

Inflammation

6

Ophthalmology

6

Metabolic

5

Infectious Diseases

4

Medtech

4

Other

8


-----------

Total

100

 

                                        

 

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

21 MARCH 2018


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBUGDXSBDBGIB
UK 100

Latest directors dealings